A Pentagon-funded fentanyl vaccine licensed to startup ARMR Sciences will begin Phase 1 in the Netherlands in early 2026. Three decades of failed addiction vaccines, and a supply chain that runs through Chinese precursor labs, are the context the press release leaves out.
Infectious DiseaseA British prosthetics graduate is heading to NHS ambulance crews and the British military to build realistic trauma wounds, the artisan end of the twenty-year battlefield-medicine revolution that turned hemorrhage into a survivable injury.
Nutrition & FoodA non-randomized trial of 36 English discount stores produced a moment-of-implementation bump in produce sales that lost statistical significance by three months, and a household-purchasing signal that never landed. The authors' immediate call for a national layout mandate is the louder finding.
Infectious DiseaseA new global synthesis on free-living amoebae explains why a single bad month at a public splash pad is enough to kill a child, and why the CDC's existing protocol would have caught it.
InvestigationsA Senate Homeland Security subcommittee took testimony on whether mRNA COVID shots can plausibly cause cancer, and on the parallel campaign to keep that question out of the journals. Dr. John Campbell walked his audience through it.
Nutrition & FoodA May 2026 review by two geriatric researchers, syndicated this week by ScienceDaily, restates what twenty years of trial data have already shown: the supplement aisle is built around vague promises older Americans do not need, while protein, the gap that actually moves aging outcomes, sits in the m
Drugs & FDAAlnylam paid Inceptive Nucleics $30 million up front, with up to $2 billion in milestones tied to outcomes the rest of AI drug discovery has spent a decade failing to deliver.
InvestigationsTwo NIAID scientists are charged with bringing 113 undeclared vials into Detroit during an active Congo mpox outbreak. One allegedly told a federal officer he does it all the time.
Infectious DiseaseThe FDA approved Shionogi's ensitrelvir for post-exposure COVID prevention, citing a 67% relative risk reduction. Look at what the trial actually measured and a different story comes into focus.
Drugs & FDAThe FDA cleared bulevirtide for chronic hepatitis delta this week, six years after Europe started using it and three years after a U.S. application was turned down on manufacturing grounds. The wait is its own story.
Infectious DiseaseWashington has built a wall around the Ebola outbreak in Central Africa. The last time America tried this, the evidence says the wall leaked, and so did the response.
InvestigationsDoctor Mike's lighthearted Never Have I Ever video sits at the top of a funnel that includes a $997 media academy, a UNICEF vaccine-ambassador title, and an ongoing pitch to pharmaceutical executives about social-media trust.